Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
10.1002/ijc.33822
Saved in:
Main Authors: | Huang, Yiqing, Soon, Yu Yang, Aminkeng, Folefac, Tay, Sen Hee, Ang, Yvonne, Kee, Adrian CL, Goh, Boon Cher, Wong, Alvin SC, Soo, Ross A |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Language: | English |
Published: |
WILEY
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/235038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients
by: Huang, Y, et al.
Published: (2023) -
Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
by: Ngoi, NYL, et al.
Published: (2021) -
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
by: Chuah, Samuel, et al.
Published: (2022) -
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022) -
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
by: Wang, Dongdong, et al.
Published: (2023)